Literature DB >> 19725258

Restless legs syndrome in a community sample of Korean adults: prevalence, impact on quality of life, and association with DSM-IV psychiatric disorders.

Seong-Jin Cho1, Jin Pyo Hong, Bong-Jin Hahm, Hong Jin Jeon, Sung Man Chang, Maeng Je Cho, Hochang B Lee.   

Abstract

STUDY
OBJECTIVES: Conflicting reports on prevalence of RLS exist in Asian countries due to differences in sampling strategies and assessment instruments. We assessed the prevalence, correlates, quality of life, and psychiatric comorbidity of RLS in South Korea. DESIGN/
SETTING: Cross-sectional nationwide survey. PARTICIPANTS: Nationally representative sample of 6,509 Korean adults aged 18-64. MEASUREMENT &
RESULTS: Face-to-face interviews based on the Korean translation of the four features of RLS defined by the International RLS Study Group (IRLSSG), the Korean version of Composite International Diagnostic Interview (K-CIDI), and EuroQol (EQ-5D) were conducted for all participants. The weighted prevalence of RLS in South Korea was 0.9% (men, 0.6%; women, 1.3%). Subjects with RLS had a lower quality of life according to EQ-5D than those without RLS. Adjusted odds ratio for lifetime diagnosis of DSM-IV major depressive disorder (2.57, 95% confidence interval [1.33, 4.96]), panic disorder (18.9 [4.72, 75.9]) and posttraumatic stress disorder (3.76 [1.32, 10.7]) suggest strong association between RLS and DSM-IV depression and anxiety disorders.
CONCLUSIONS: Prevalence of RLS estimated based on the IRLSSG diagnostic criteria is substantially lower in South Korea than in Western countries. Differences in culture and risk factors that affect the expression of RLS may vary across the countries.

Entities:  

Mesh:

Year:  2009        PMID: 19725258      PMCID: PMC2717197     

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  32 in total

1.  Psychiatric epidemiology in Korea. Part I: Gender and age differences in Seoul.

Authors:  C K Lee; Y S Kwak; J Yamamoto; H Rhee; Y S Kim; J H Han; J O Choi; Y H Lee
Journal:  J Nerv Ment Dis       Date:  1990-04       Impact factor: 2.254

2.  Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms.

Authors:  J Ulfberg; B Nyström; N Carter; C Edling
Journal:  Mov Disord       Date:  2001-11       Impact factor: 10.338

3.  Restless legs syndrome in an Asian population: A study in Singapore.

Authors:  E K Tan; A Seah; S J See; E Lim; M C Wong; K K Koh
Journal:  Mov Disord       Date:  2001-05       Impact factor: 10.338

Review 4.  Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health.

Authors:  Richard P Allen; Daniel Picchietti; Wayne A Hening; Claudia Trenkwalder; Arthur S Walters; Jacques Montplaisi
Journal:  Sleep Med       Date:  2003-03       Impact factor: 3.492

5.  Unexpectedly low prevalence and unusual characteristics of RLS in Mersin, Turkey.

Authors:  S Sevim; O Dogu; H Camdeviren; R Bugdayci; T Sasmaz; H Kaleagasi; M Aral; I Helvaci
Journal:  Neurology       Date:  2003-12-09       Impact factor: 9.910

6.  Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys.

Authors:  Koen Demyttenaere; Ronny Bruffaerts; Jose Posada-Villa; Isabelle Gasquet; Viviane Kovess; Jean Pierre Lepine; Matthias C Angermeyer; Sebastian Bernert; Giovanni de Girolamo; Pierluigi Morosini; Gabriella Polidori; Takehiko Kikkawa; Norito Kawakami; Yutaka Ono; Tadashi Takeshima; Hidenori Uda; Elie G Karam; John A Fayyad; Aimee N Karam; Zeina N Mneimneh; Maria Elena Medina-Mora; Guilherme Borges; Carmen Lara; Ron de Graaf; Johan Ormel; Oye Gureje; Yucun Shen; Yueqin Huang; Mingyuan Zhang; Jordi Alonso; Josep Maria Haro; Gemma Vilagut; Evelyn J Bromet; Semyon Gluzman; Charles Webb; Ronald C Kessler; Kathleen R Merikangas; James C Anthony; Michael R Von Korff; Philip S Wang; Traolach S Brugha; Sergio Aguilar-Gaxiola; Sing Lee; Steven Heeringa; Beth-Ellen Pennell; Alan M Zaslavsky; T Bedirhan Ustun; Somnath Chatterji
Journal:  JAMA       Date:  2004-06-02       Impact factor: 56.272

7.  Sex and the risk of restless legs syndrome in the general population.

Authors:  Klaus Berger; Jan Luedemann; Claudia Trenkwalder; Ulrich John; Christof Kessler
Journal:  Arch Intern Med       Date:  2004-01-26

8.  The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research.

Authors:  D J Buysse; C F Reynolds; T H Monk; S R Berman; D J Kupfer
Journal:  Psychiatry Res       Date:  1989-05       Impact factor: 3.222

9.  Rates of symptoms of depression in a national sample.

Authors:  W W Eaton; L G Kessler
Journal:  Am J Epidemiol       Date:  1981-10       Impact factor: 4.897

10.  Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions.

Authors:  Juliane Winkelmann; Barbara Schormair; Peter Lichtner; Stephan Ripke; Lan Xiong; Shapour Jalilzadeh; Stephany Fulda; Benno Pütz; Gertrud Eckstein; Stephanie Hauk; Claudia Trenkwalder; Alexander Zimprich; Karin Stiasny-Kolster; Wolfgang Oertel; Cornelius G Bachmann; Walter Paulus; Ines Peglau; Ilonka Eisensehr; Jacques Montplaisir; Gustavo Turecki; Guy Rouleau; Christian Gieger; Thomas Illig; H-Erich Wichmann; Florian Holsboer; Bertram Müller-Myhsok; Thomas Meitinger
Journal:  Nat Genet       Date:  2007-07-18       Impact factor: 38.330

View more
  31 in total

Review 1.  Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment.

Authors:  Paul Yeh; Arthur S Walters; John W Tsuang
Journal:  Sleep Breath       Date:  2011-10-26       Impact factor: 2.816

2.  Restless legs syndrome: relationship between prevalence and latitude.

Authors:  Brian B Koo
Journal:  Sleep Breath       Date:  2011-12-31       Impact factor: 2.816

Review 3.  Prevalence of restless legs syndrome in North American and Western European populations: a systematic review.

Authors:  Kim E Innes; Terry Kit Selfe; Parul Agarwal
Journal:  Sleep Med       Date:  2011-07-12       Impact factor: 3.492

4.  Ethnic differences in the prevalence and predictors of restless legs syndrome between Hispanics of Mexican descent and non-Hispanic Whites in San Diego county: a population-based study.

Authors:  Kittisak Sawanyawisuth; Lawrence A Palinkas; Sonia Ancoli-Israel; Joel E Dimsdale; José S Loredo
Journal:  J Clin Sleep Med       Date:  2013-01-15       Impact factor: 4.062

5.  Prospective study of restless legs syndrome and risk of depression in women.

Authors:  Yanping Li; Fariba Mirzaei; Eilis J O'Reilly; John Winkelman; Atul Malhotra; Olivia Ifeoma Okereke; Alberto Ascherio; Xiang Gao
Journal:  Am J Epidemiol       Date:  2012-07-17       Impact factor: 4.897

Review 6.  Nocturia × disturbed sleep: a review.

Authors:  Daniele Furtado; Helena Hachul; Monica L Andersen; Rodrigo A Castro; Manoel B Girão; Sergio Tufik
Journal:  Int Urogynecol J       Date:  2011-08-17       Impact factor: 2.894

Review 7.  Sleep-related movement disorders.

Authors:  Giovanni Merlino; Gian Luigi Gigli
Journal:  Neurol Sci       Date:  2011-12-28       Impact factor: 3.307

Review 8.  Imaging brain functional and metabolic changes in restless legs syndrome.

Authors:  Giovanni Rizzo; Caterina Tonon; David Manners; Claudia Testa; Raffaele Lodi
Journal:  Curr Neurol Neurosci Rep       Date:  2013-09       Impact factor: 5.081

9.  Psychosomatic symptom profiles in patients with restless legs syndrome.

Authors:  Jung Bin Kim; Yong Seo Koo; Mi-Yeon Eun; Kun-Woo Park; Ki-Young Jung
Journal:  Sleep Breath       Date:  2013-01-23       Impact factor: 2.816

10.  The Effect of Gabapentin Enacarbil on Quality of Life and Mood Outcomes in a Pooled Population of Adult Patients with Moderate-to-Severe Primary Restless Legs Syndrome.

Authors:  Alon Y Avidan; Daniel Lee; Margaret Park; Mark J Jaros; Gwendoline Shang; Richard Kim
Journal:  CNS Drugs       Date:  2016-04       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.